Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marek Minarik

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Talanta|March 1, 2025
3D-printed device for time- and cost-efficient sample preparation and DNA fractionationHelena Hrušková, Roman Řemínek, Marek Minarik, et al.
Electrophoresis|April 20, 2004
Application of cycling gradient capillary electrophoresis to detection of APC, K-ras, and DCC point mutations in patients with sporadic colorectal tumorsMarek Minarik, Lucie Minarikova, Michala Hrabikova, et al.
Forensic Science International. Genetics|March 11, 2010
Assembly of a large Y-STR haplotype database for the Czech population and investigation of its substructureJan Zastera, Lutz Roewer, Sascha Willuweit, et al.
Tumori|July 31, 2014
Retreatment with erlotinib of a patient with metastatic NSCLC harboring EGFR mutation: a case reportOndrej Fiala, Milos Pesek, Jindrich Finek, et al.
Cancer Genetics|January 15, 2013
The dominant role of G12C over other KRAS mutation types in the negative prediction of efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancerOndrej Fiala, Milos Pesek, Jindrich Finek, et al.
Anticancer Research|July 31, 2013
Sequential treatment of advanced-stage lung adenocarcinoma harboring wild-type EGFR gene: second-line pemetrexed followed by third-line erlotinib versus the reverse sequenceOndrej Fiala, Milos Pesek, Jindrich Finek, et al.
American Journal of Medical Genetics. Part A|November 18, 2008
Somatic TP53 mutation mosaicism in a patient with Li-Fraumeni syndromeKamila Prochazkova, Kristyna Pavlikova, Marek Minarik, et al.
Anticancer Research|April 9, 2013
Gene mutations in squamous cell NSCLC: insignificance of EGFR, KRAS and PIK3CA mutations in prediction of EGFR-TKI treatment efficacyOndrej Fiala, Milos Pesek, Jindrich Finek, et al.
Journal of Separation Science|May 24, 2018
Application of denaturing capillary electrophoresis for the detection of prognostic mutations in isocitrate dehydrogenase 1 and isocitrate dehydrogenase 2 genes in brain tumorsLucie Benesova, Barbora Belsanova, Filip Kramar, et al.
Electrophoresis|September 15, 2006
Parallel optimization and genotyping of multiple single-nucleotide polymorphism markers by sample pooling approach using cycling-gradient CE with multiple injectionsMarek Minarik, Lucie Benesova, Lucie Fantova, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Talanta|March 1, 2025
3D-printed device for time- and cost-efficient sample preparation and DNA fractionationHelena Hrušková, Roman Řemínek, Marek Minarik, et al.
Electrophoresis|April 20, 2004
Application of cycling gradient capillary electrophoresis to detection of APC, K-ras, and DCC point mutations in patients with sporadic colorectal tumorsMarek Minarik, Lucie Minarikova, Michala Hrabikova, et al.
Forensic Science International. Genetics|March 11, 2010
Assembly of a large Y-STR haplotype database for the Czech population and investigation of its substructureJan Zastera, Lutz Roewer, Sascha Willuweit, et al.
Tumori|July 31, 2014
Retreatment with erlotinib of a patient with metastatic NSCLC harboring EGFR mutation: a case reportOndrej Fiala, Milos Pesek, Jindrich Finek, et al.
Cancer Genetics|January 15, 2013
The dominant role of G12C over other KRAS mutation types in the negative prediction of efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancerOndrej Fiala, Milos Pesek, Jindrich Finek, et al.
Anticancer Research|July 31, 2013
Sequential treatment of advanced-stage lung adenocarcinoma harboring wild-type EGFR gene: second-line pemetrexed followed by third-line erlotinib versus the reverse sequenceOndrej Fiala, Milos Pesek, Jindrich Finek, et al.
American Journal of Medical Genetics. Part A|November 18, 2008
Somatic TP53 mutation mosaicism in a patient with Li-Fraumeni syndromeKamila Prochazkova, Kristyna Pavlikova, Marek Minarik, et al.
Anticancer Research|April 9, 2013
Gene mutations in squamous cell NSCLC: insignificance of EGFR, KRAS and PIK3CA mutations in prediction of EGFR-TKI treatment efficacyOndrej Fiala, Milos Pesek, Jindrich Finek, et al.
Journal of Separation Science|May 24, 2018
Application of denaturing capillary electrophoresis for the detection of prognostic mutations in isocitrate dehydrogenase 1 and isocitrate dehydrogenase 2 genes in brain tumorsLucie Benesova, Barbora Belsanova, Filip Kramar, et al.
Electrophoresis|September 15, 2006
Parallel optimization and genotyping of multiple single-nucleotide polymorphism markers by sample pooling approach using cycling-gradient CE with multiple injectionsMarek Minarik, Lucie Benesova, Lucie Fantova, et al.
Pageof 6